ProEthic to Present at Wachovia Securities Small and Mid-Cap Healthcare Conference.MONTGOMERY, Ala. -- ProEthic Pharmaceuticals, Inc., a privately funded specialty pharmaceutical company that acquires, develops, licenses and markets niche prescription products, today announced that Carl Whatley, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will be presenting at the Wachovia Securities Small and Mid-Cap Healthcare Conference on Wednesday, January 31st, 11:15 a.m., EST EST electroshock therapy. EST abbr. electroshock therapy at the Langham Hotel's Palmer Boardroom, Boston, Massachusetts. Mr. Whatley will present a company overview. About ProEthic Pharmaceuticals, Inc. ProEthic is an emerging specialty pharmaceutical company enhancing treatment strategies initially in the areas of pain and migraine. Founded in 2001, the privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. focuses its efforts on the acquisition, development, licensing, and marketing of pharmaceutical products. ProEthic also markets niche generic prescription pharmaceutical products through Midlothian Laboratories LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. . For more information, please visit the ProEthic website at: www.proethic.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion